Recurrent hypoglycemia in a patient with advanced Hepatocellular Carcinoma
Management of hypoglycemia is usually challenging given patients are usually not good candidates for aggressive therapies given advanced cancer stage and/or poor general condition. Paraneoplastic hypoglycemia is usually a poor prognostic indicator. Experimental treatment options for hypoglycemia include steroids, glucagon and growth hormone.
Authors
- Balpreet Chouhan
Institutions
- Kaiser Permanente (US)
Publication Details
- Journal
- Journal of Community Hospital Internal Medicine Perspectives
- Published
- 2024-11-02
- DOI
- https://doi.org/10.55729/2000-9666.1406
- Primary Topic
- Cancer, Hypoxia, and Metabolism
- Type
- article
- Field-Weighted Citation Impact
- 0.00